PureHealth, the largest healthcare group in the Middle East, today announced that it has exceeded AED6.33 billion ($1.72 billion) in local procurement spend since joining the Ministry of Industry and Advanced Technology’s (MoIAT) National In-Country Value (ICV) programme, in 2022.
Arada has acquired a significant controlling stake in Reem Hospital, the Abu Dhabi-based healthcare provider, in a move that marks the master developer's entry into the healthcare sector and accelerates its ambition to build one of the region's most comprehensive integrated wellness ecosystems.
Expo City Dubai Foundation has awarded funding to seven global projects under its Global Innovators Programme, focused on tackling extreme heat challenges across the Global South.
LIFEPharma, a USFDA approved pharmaceutical manufacturer and a part of VPS Health, has announced the establishment of a dedicated spin off biotech focused on end to end development of cell and gene therapies.
Saudi Arabia's Ministry of Health (MoH), the Ministry of Defense (MoD) and the National Center for Privatization & PPP (NCP) have launched the Expression of Interest (EOI) and Request for Qualification (RFQ) phase for a major renal care project.
The next edition of WHX Tech will take place from January 27–29, 2027 at the Dubai World Trade Centre (DWTC). The event will run alongside World Health Expo (WHX), the flagship global healthcare event.
PureHealth Holding, the largest healthcare group in the Middle East, reported a revenue increase of 10% year-on-year in the first quarter to AED7.3 billion ($1.99, driven by strong growth in PureHealth’s international Care (healthcare) portfolio and the Cover (insurance) vertical.
The Emirates Drug Establishment (EDE) has officially granted approval for EURneffy, a novel epinephrine-based treatment available in 1 mg and 2 mg strengths, making the UAE the first country in the region to authorise this innovative therapy.
Novo Nordisk has announced positive topline results from Pioneer Teens, a phase 3a trial evaluating oral semaglutide for type 2 diabetes in children and adolescents aged 10–17 years.
NMC Healthcare Group (NMC), a leading integrated private healthcare provider in the United Arab Emirates, has opened a new clinic in Al Riyadh City, Abu Dhabi.
